Cart
sales@molnova.com
WDR5-0103 hydrochloride
CAS No. ——
WDR5-0103 hydrochloride( WD-Repeat Protein 5-0103 )
Catalog No. M19925 CAS No. ——
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | Get Quote |
|
| 5MG | 76 | Get Quote |
|
| 10MG | 132 | Get Quote |
|
| 25MG | 239 | Get Quote |
|
| 50MG | 414 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWDR5-0103 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionWDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
-
DescriptionWDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsWD-Repeat Protein 5-0103
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorWDR5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight419.9
-
Molecular FormulaC21H26ClN3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 45 mg/mL;Ethanol: 18 mg/mL;Water: Insoluble
-
SMILESCl.COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cccc(OC)c2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Senisterra G et al. Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5. Biochem J. 2013 Jan 1;449(1):151-159.
molnova catalog
related products
-
Tofacitinib citrate
A potent, specific, orally active inhibitor of JAK3 with IC50 of 1 nM in cell-free assays; displays 20- to 100-fold less potency for JAK2 and JAK1 (IC50=20 nM and 112 nM, respectively).
-
Londamocitinib
Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
-
WDR5-IN-6
WDR5-IN-6 is a WDR5 inhibitor targeting the WBM locus and is highly synergistic with OICR-9429, a WDR5 inhibitor that targets the WIN locus.
